glp 1 agonist and dementia Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline in Diabetes Mellitus GLP-1 Agonists and Dementia -
Description
Does this new weight loss drug work better than Wegovy and Ozempic

The study was presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and published on June 2 in JCO Oncology Practice

GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist-Induced Nausea and Emesis in Preclinical Models

His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools

Oxyntomodulin: actions and role in diabetes

payment for expert testimony from UCB
